Crinetics Pharmaceuticals Inc buy Morgan Stanley
Start price
23.05.24
/
50%
€44.80
Target price
23.05.25
€64.64
Performance (%)
-42.86%
End price
24.05.25
€25.60
Summary
This prediction ended on 24.05.25 with a price of €25.60. Massive losses of -42.86% were the result for the BUY prediction by Morgan_Stanley. Morgan_Stanley has a follow-up prediction for Crinetics Pharmaceuticals Inc where he still thinks Crinetics Pharmaceuticals Inc is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Crinetics Pharmaceuticals Inc | 0.485% | 0.485% | -20.385% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Morgan_Stanley for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Morgan Stanley from $50.00 to $70.00. They now have an "overweight" rating on the stock.
Ratings data for CRNX provided by MarketBeat
In the thread Trading Crinetics Pharmaceuticals Inc
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€37.40
29.09.25
29.09.25
€65.69
29.09.26
29.09.26
10.70%
16.12.25
16.12.25
